Identification of nine new susceptibility loci for endometrial cancer. Nat Commun. 2018; 9:3166
O'Mara TA, Glubb DM, Amant F, et al
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. J Pathol Clin Res. 2018; 4:250-261
Rambau PF, Vierkant RA, Intermaggio MP, et al
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nat Genet. 2018; 50:968-978
Wu L, Shi W, Long J, et al
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res. 2018; 78:5419-5430
Lu Y, Beeghly-Fadiel A, Wu L, et al
The National Cancer Institute Cohort Consortium: An International Pooling Collaboration of 58 Cohorts from 20 Countries. Cancer Epidemiol Biomarkers Prev. 2018; 27:1307-1319
Swerdlow AJ, Harvey CE, Milne RL, et al
Analgesic use and ovarian cancer risk: an analysis in the Ovarian Cancer Cohort Consortium. JNCI 2018
Trabert B, Poole EM, White E et al
Breast cancer risk in relation to history of preeclampsia and hyperemesis gravidarum: Prospective analysis in the Generations Study. Int J Cancer. 2018; 143:782-792
Wright LB, Schoemaker MJ, Jones ME, Ashworth A, Swerdlow AJ
Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. Int J Cancer. 2018; 143:746-757
Abubakar M, Chang-Claude J, Ali HR et al
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Hum Mutat. 2018;39:729-741
Colombo M, Lòpez-Perolio I, Meeks HD, et al
Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study. Br J Cancer 2018;118:600-606
Johns LE, Jones ME, Schoemaker MJ, McFadden E, Ashworth A, Swerdlow AJ
